[Form 3] OnKure Therapeutics, Inc. Initial Statement of Beneficial Ownership
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
OnKure Therapeutics, Inc. reported the initial ownership of a major shareholder group led by AI Biotechnology LLC. The filing shows AI Biotechnology holds pre-funded warrants exercisable for 5,640,222 shares of Class A Common Stock at an exercise price of $0.0001 per share, plus 3,998,332 shares of Class A Common Stock.
The pre-funded warrants are subject to a Beneficial Ownership Blocker, limiting exercises so that AI Biotechnology’s beneficial ownership does not exceed 9.99% of outstanding Class A Common Stock, unless increased (with notice) up to but not above 19.99%. Access Industries entities and Len Blavatnik may be deemed indirect beneficial owners but disclaim beneficial ownership beyond their pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
AI Biotechnology LLC, Access Industries Holdings LLC, ACCESS INDUSTRIES MANAGEMENT, LLC, Blavatnik Len
Role
10% Owner | 10% Owner | 10% Owner | 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Warrant (right to buy) | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Warrant (right to buy) — 5,640,222 shares (Direct);
Class A Common Stock — 3,998,332 shares (Direct)
Footnotes (1)
- Each whole pre-funded warrant entitles AI Biotechnology LLC ("AIB") to purchase one share of Class A Common Stock at an exercise price equal to $0.0001 per share, and may be exercised at any time or times on or after the date of issuance, subject to the Beneficial Ownership Blocker (as defined herein). The pre-funded warrants are not exercisable to the extent that the aggregate number of Class A Common Stock beneficially owned by AIB immediately following such exercise would exceed 9.99% of the Class A Common Stock outstanding, as calculated under Rule 13d-3 of the Securities Exchange Act of 1934, as amended; provided, however, that AIB may increase or decrease the beneficial ownership limitation by giving notice to the Issuer (such notice not to be effective until the sixty-first day after the notice is delivered to the Issuer), but not to exceed any percentage in excess of 19.99% (such limitations, the "Beneficial Ownership Blocker"). The securities reported are held directly by AIB and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, and (iii) AIH owns all of the voting units of AIB. Each of AIH, AIM and Mr. Blavatnik, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.
